We are leaders in Reproductive Medicine with personalized treatments and cutting edge technology. Specialists in Poor Ovarian Response and Implantation Failure.
We understand that many people long to have children. When it does not happen natyrally, it’s essential that people turn to the very best specialists in the field.
Our fertility clinic in Alicante has a team of experts, the latest in technology and in-house laboratories both for reproductive biology and for genetics and analysis. We also carry out several research projects with a view to developing new therapies and improving our reproduction treatments. This means we are able to give patients the latest in reproductive medicine and the best options for getting pregnant.
We guarantee the very best care at each step of the assisted reproduction treatment process. We look after and treat not only the individual but, in particular, the embryo – your child. This is why over 60,000 patients from 63 countries have turned to us and we have become leaders in personalised and specialised treatment.
Dutch, English, French, German, Russian, Spanish
Selection the most suitable egg donor
Egg donation in Spain is anonymous and altruistic, according to current Spanish legislation. Before a female donor is assigned to a recipient couple, she undergoes a strict battery of tests administered by our multidisciplinary team.
These tests include:
• Medical, psychological and gynaecological examinations
• Blood and serological tests for infectious diseases
• Karyotype and a study of her genetic history to rule out the most common hereditary illnesses.
The donor then undergoes ovary stimulation to obtain an adequate number of oocytes. The retrieved oocytes are then fertilised and days later, when the resulting embryos reach their optimum state of development, they are transferred to the recipient mother’s uterus.
At Instituto Bernabeu, we perform rigorous and comprehensive screenings of donor candidates, includingpsychological, clinical and genetic evaluations, in order to maximize the suitability and safety of the procedure:
1. A psychological evaluation performed by a clinical psychologist. This evaluation includes a personal interview and completing our Psychological Evaluation Questionnaire (EMAE) to evaluate the candidate’s personality.
2. An evaluation of the candidate’s personal and family history performed by a gynecologist specialized in fertility, and a physical and gynecological examination that shows the candidate’s good state of health and excludes the possibility of a gynecologic pathology.
3. Chromosomal and genetic studies to rule out the possible presence of hereditary diseases: Karyotype (including chromosomal polymorphisms associated with an increased risk ofmiscarriage), screening for Fragile X Syndrome, Thalassemia, Spinal Muscular Atrophy (SMA) and the study of 552 genes linked to over 600 autosomal recessive diseases (CGT: The most comprehensive genetic compatibility test). The future father can take the CGT in parallel to contrast the results with the egg donor in order to avoid transmitting diseases to offspring. In addition, the DNA extracted for genetic testing is stored in a biobank for future testing.
4. General laboratory tests: blood type and Rh factor, syphilis serology, hepatitis B and C serology, HIV serology, and coagulation tests.
5. Tests for Cytomegalovirus (CMV).
6. Screening of the 10 most common sexually transmitted diseases (chlamydia, gonorrhoea, herpes I and II, trichomonas, Treponema, Mycoplasma hominis and genitalium, ureaplasma, haemophilus).
Statistics following the first cycle in Instituto Bernabeu, 2015.
The cumulative pregnancy rate refers to pregnancies achieved following the egg retrieval/collection procedure. This includes transfer of fresh embryos and a possible transfer of frozen embryos.
|CUMULATIVE % OF PREGNANCIES ACHIEVED IN EGG DONATION TREATMENTS||Rate|
|CUMULATIVE % OF PREGNANCIES ACHIEVED||81,5%|
|FRESH EGG DONATION (We coordinate to ensure fresh egg donation, except where the opposite is expressly requested by the receptor)||97%|
|EGG DONATION CYCLES THAT FREEZE EMBRYOS||87%|
|TRANSFERS ON DAY 5 (BLASTOCYST)||90%|
|EMBRYOS THAT REACH THE BLASTOCYST STAGE (5 DAYS OF DEVELOPMENT)||70%|
|MATURE EGGS DONATED PER CYCLE||We guarantee a minimum of 6 and an average of 10.5 per cycle|
|CUMULATIVE % OF PREGNANCIES ACHIEVED FROM IN VITRO FERTILISATION (IVF) TREATMENTS||Rate|
|PATIENTS UNDER 35 YEARS OF AGE||78,7%|
|PATIENTS BETWEEN 35 AND 39 YEARS OF AGE||68,8%|
|PATIENTS AGED 40 YEARS OR OVER||54,1%|
|EMBRYOS THAT REACH THE BLASTOCYST STAGE (5 DAYS OF DEVELOPMENT)||60%|
|IVF CYCLES THAT FREEZE EMBRYOS||60%|
|CUMULATIVE % OF PREGNANCIES ACHIEVED IN ADOPTED FROZEN EMBRYO TREATMENTS||45,2%|
The aim is NOT to get achieve a positive pregnancy test. It is the birth of a healthy child that is not premature and is born following a satisfactory and complication-free pregnancy.
Our results are held on the register at the Spanish Fertility Society (SEF) and have been audited by external companies TÜVRheinland® and Instituto Fidelitas.
A "clinical pregnancy" has a pregnancy sac seen in the uterus on ultrasound exam.
The "live birth rate" is the percentage of all IVF cycles that lead to a live birth. This rate does not include miscarriage or still birth and multiple-order births such as twins and triplets are counted as one pregnancy.
|Fresh donor egg embryos||Thawed donor egg embryos|
Learn more about success rates.
Private Insurance:(only CASER)
Legislation in Spain and Europe on Assisted Reproduction
The current Spanish legislation, LAW 14/2006 of 26 May, on human assisted reproduction techniques, contemplates the absolute anonymity of gamete donors, in such a way that their identity may never be revealed. The donation is considered an altruistic act.
Any woman over 18 years old and in full capacity to act can receive or use Assisted Reproduction Techniques regulated by law, independently of her marital status and her sexual orientation. Therefore, single women, married heterosexual and homosexual couples, and legally registered heterosexual partners qualify for assisted reproduction. More importantly, Law 14/2006 provides for reproduction techniques to be used not only to treat fertility problems, but also for reproductive life planning (e.g. choosing single parenting, postponing motherhood with the patient’s own gametes by means of oocyte cryopreservation techniques, and so on).
Download here the complete text of Law 14/2006 (in Spanish) (the link is extracted from this section)
Current Spanish Legislation allows reproduction treatments that are prohibited in many other countries.
*Only for cases of gender related hereditary disease.
Regarding the qualifying conditions to receive or use the techniques, legislation only requires, in addition to being over 18 years old, a reasonable chance of success for the proposed treatment, no serious risks having been identified for the patient’s physical or psychical health or her potential offspring’s, and obtaining the patient’s free and informed acceptance, which she must grant by signing an informed consent.
It must be clearly stated that surrogate pregnancy is strictly forbidden by Spanish law, since motherhood is conferred to the woman who carries the pregnancy.
Regarding those techniques regulated by law, unlike legislation in other countries, which is more restrictive, treatments using donated gametes (both sperm and eggs) stand out. In this respect, two fundamental aspects must be highlighted: first, donation is confidential and therefore born children and recipients have the right to receive general information about their donors provided that donor identity is not disclosed; secondly, donor selection can only be conducted by the medical team applying the technique. Donors cannot be personally selected by the recepient under any circumstances, even though at Bernabéu Institute we try our best to find the best possible match.
Today, while it is not covered in the legal provisions in force, it is possible to use the technique known as ROPA (Reception of Oocytes from Partner), which makes it possible for two women who are married to take part in the treatment and become parents. One of them provides oocytes that are subsequently inseminated with the sperm of an anonymous donor. The other receives the embryos and becomes pregnant. After consenting to the treatment, one becomes a genetic mother and the other a birth mother. To these effects, two-mother families have been legally recognized in Spain since 2007 under the provision that the two mothers are married. As a consequence, babies who are born using a ROPA treatment can be legally registered in Spain as having two mothers.
Profile (Clinic/Professional) incorrect or not updated? Please contact us
Get for FREE the following e-books: